blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1673630

EP1673630 - MN/CA IX AND CANCER PROGNOSIS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.02.2012
Database last updated on 25.09.2024
Most recent event   Tooltip17.02.2012Application deemed to be withdrawnpublished on 21.03.2012  [2012/12]
Applicant(s)For all designated states
INSTITUTE OF VIROLOGY
Slovak Academy of Sciences, Dubravska Cesta 9
842 46 Bratislava / SK
[2006/26]
Inventor(s)01 / EBERT, Matthias
Lentkestrasse 57
39116 Magdeburg / DE
02 / ROCKEN, Christoph
Brunnerstrasse 24
39112 Magdeburg / DE
03 / PASTOREKOVA, Silvia
Novoveska 18
841 07 Bratislava / SK
04 / ZAVADA, Jan
Na pekne vyhlidce 1
162 00 Prague / CZ
05 / PASTOREK, Jaromir
Novoveska 18
841 07 Bratislava / SK
 [2006/26]
Representative(s)Behnisch, Werner, et al
ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / DE
[N/P]
Former [2010/48]Behnisch, Werner, et al
Reinhard, Skuhra, Weise & Partner GbR Patent- und Rechtsanwälte Friedrichstrasse 31
80801 München / DE
Former [2009/49]Froud, Clive
Clive Froud & Co Limited 7 Hurst Close Tenterden Ashford
Kent TN30 6UG / GB
Former [2006/26]Froud, Clive
Clive Froud & Co Limited 7 Hurst Close Tenterden
GB-Kent TN30 6UG / GB
Application number, filing date04795702.218.10.2004
[2006/26]
WO2004US34573
Priority number, dateUS20030511832P16.10.2003         Original published format: US 511832 P
[2006/26]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005037083
Date:28.04.2005
Language:EN
[2005/17]
Type: A2 Application without search report 
No.:EP1673630
Date:28.06.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 28.04.2005 takes the place of the publication of the European patent application.
[2006/26]
Search report(s)International search report - published on:US24.11.2005
(Supplementary) European search report - dispatched on:EP01.04.2009
ClassificationIPC:G01N33/534, G01N33/574
[2009/15]
CPC:
G01N33/5748 (EP,US); C07K14/82 (EP,US); C12N9/88 (EP,US);
C12Q1/6886 (EP,US); G01N33/57484 (EP,US); C12Q2600/118 (EP,US);
C12Q2600/154 (EP,US); G01N2333/82 (EP,US) (-)
Former IPC [2006/26]G01N33/534
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/26]
Extension statesALNot yet paid
HRNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:MN/CA IX UND KREBSPROGNOSE[2006/26]
English:MN/CA IX AND CANCER PROGNOSIS[2006/26]
French:MN/AC IX ET PRONOSTIC DU CANCER[2006/26]
Entry into regional phase16.03.2006National basic fee paid 
16.03.2006Search fee paid 
16.03.2006Designation fee(s) paid 
16.03.2006Examination fee paid 
Examination procedure16.03.2006Examination requested  [2006/26]
20.06.2006Amendment by applicant (claims and/or description)
08.07.2009Despatch of a communication from the examining division (Time limit: M04)
29.10.2009Reply to a communication from the examining division
20.01.2011Date of oral proceedings
01.02.2011Despatch of a communication from the examining division (Time limit: M02)
01.02.2011Minutes of oral proceedings despatched
01.04.2011Reply to a communication from the examining division
13.05.2011Communication of intention to grant the patent
24.09.2011Application deemed to be withdrawn, date of legal effect  [2012/12]
03.11.2011Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2012/12]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.07.2009
Fees paidRenewal fee
27.10.2006Renewal fee patent year 03
29.10.2007Renewal fee patent year 04
27.10.2008Renewal fee patent year 05
26.10.2009Renewal fee patent year 06
25.10.2010Renewal fee patent year 07
25.10.2011Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PX]  - J. HOFFMANN ET AL, "Carbonic Anhydrase IX (CA9) Expression in Gastric Cancer is Associated with Enhanced Invasion and Poor Prognosis", HELICOBACTER, online, (20040909), vol. 9, no. 5, page 492, XP002407342 [PX] 1-11 * abstract *
 [PX]  - BIRNER PETER ET AL, "Expression of hypoxia-related tissue factors correlates with diminished survival of adjuvantly treated patients with chromosome 1p aberrant oligodendroglial neoplasms and therapeutic implications.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH. 1 OCT 2004, (20041001), vol. 10, no. 19, ISSN 1078-0432, pages 6567 - 6571, XP002407933 [PX] 1-3,5,7-11 * page 6569, column L, paragraph 2 *

DOI:   http://dx.doi.org/10.1158/1078-0432.CCR-04-0617
 [DA]  - LEPPILAMPI MARI ET AL, "Carbonic anhydrase isozymes IX and XII in gastric tumors.", WORLD JOURNAL OF GASTROENTEROLOGY : WJG. JUL 2003, (200307), vol. 9, no. 7, ISSN 1007-9327, pages 1398 - 1403, XP009074813 [DA] 1-11 * abstract *
 [DA]  - SAARNIO JUHA ET AL, "Transmembrane carbonic anhydrase, MN/CA IX, is a potential biomarker for biliary tumours.", JOURNAL OF HEPATOLOGY, (200111), vol. 35, no. 5, ISSN 0168-8278, pages 643 - 649, XP002407344 [DA] 1-11 * page 645, column R, paragraph 4 - page 647, column L, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0168-8278(01)00193-3
 [AD]  - POTTER C P S ET AL, "Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer.", BRITISH JOURNAL OF CANCER, (20030707), vol. 89, no. 1, ISSN 0007-0920, pages 2 - 7, XP002407934 [AD] 1-11 * page 3, column R, paragraph 3 - page 6, column R, paragraph 5 *

DOI:   http://dx.doi.org/10.1038/SJ.BJC.6600936
International search[X]US6027887  (ZAVADA JAN [CZ], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.